|Bid||0.0000 x 800|
|Ask||0.0000 x 1800|
|Day's Range||3.3800 - 3.6050|
|52 Week Range||3.1100 - 23.0505|
|Beta (5Y Monthly)||1.64|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 08, 2022 - Aug 12, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.67|
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. David Gardner: Thirty separate times, about every 10 weeks on this podcast over six years, I picked five stocks.
Bluebird (BLUE) delivered earnings and revenue surprises of -31.75% and 86.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
CAMBRIDGE, Mass., May 09, 2022--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the first quarter ended March 31, 2022, and shared recent operational progress.